|
RABIF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.425400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.226400E-01 |
| Normal-vs-Stage2 |
9.128400E-01 |
| Normal-vs-Stage3 |
2.279600E-02 |
| Normal-vs-Stage4 |
3.947400E-01 |
| Stage1-vs-Stage2 |
7.428400E-01 |
| Stage1-vs-Stage3 |
1.607630E-02 |
| Stage1-vs-Stage4 |
3.519200E-01 |
| Stage2-vs-Stage3 |
4.420300E-02 |
| Stage2-vs-Stage4 |
4.386000E-01 |
| Stage3-vs-Stage4 |
5.642600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.909400E-01 |
| Normal-vs-AfricanAmerican |
3.980000E-01 |
| Normal-vs-Asian |
4.850200E-01 |
| Caucasian-vs-AfricanAmerican |
5.841000E-01 |
| Caucasian-vs-Asian |
3.181000E-01 |
| AfricanAmerican-vs-Asian |
4.077600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.311200E-01 |
| Normal-vs-Female |
4.644900E-03 |
| Male-vs-Female |
6.806900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.924200E-01 |
| Normal-vs-Extreme_Weight |
2.977000E-01 |
| Normal-vs-Obese |
4.549600E-01 |
| Normal-vs-Extreme_Obese |
9.692600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.936620E-01 |
| Normal_Weight-vs-Obese |
8.961400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.439200E-01 |
| Extreme_Weight-vs-Obese |
1.064020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.632000E-01 |
| Obese-vs-Extreme_Obese |
7.460000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.801900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.241900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.069200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.160670E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.587030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.295800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.378600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.460300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.216700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.717900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.686600E-01 |
| Normal-VS-Type2 PRCC |
2.080200E-01 |
| Normal-VS-KIRP CIMP |
1.209030E-04 |
| Normal-VS-Unclassified PRCC |
3.139600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.347700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.425000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.035420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.847600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.117600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.180500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.391600E-01 |
| Normal-vs-N1 |
1.245600E-02 |
| Normal-vs-N2 |
7.807200E-01 |
| N0-vs-N1 |
1.220200E-02 |
| N0-vs-N2 |
6.805800E-01 |
| N1-vs-N2 |
3.804800E-01 |
|
|
